The National Community Pharmacists Association and the National Association of Chain Drug Stores has issued a joint statement in which they state that the FTC asked the two pharmacy groups for ways to revise the Medco-Express Scripts deal. The groups, who have been opposed to the acquisition, have responded with suggestions for possible remedies. However, the joint statement also affirms continued criticism of the transaction, and that their preference is for the FTC not to settle, but fight the merger in court.
Featured News
Meta Faces $887 Million Italian Privacy Fine Over Access to Android Users’ Photos
Nov 15, 2026 by
CPI
New York Social Media Warning Mandate Challenged in Federal Court
Nov 15, 2026 by
CPI
US Senator Pushes for Review of Nvidia’s ‘Too Big to Fail’ Risks
Nov 15, 2026 by
CPI
EU Escalates Antitrust Case Against Greece’s PPC Over Electricity Pricing
Nov 15, 2026 by
CPI
Consumers Seek to Break Up Paramount-Warner Bros. Merger in New Suit
Nov 15, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Data Portability
Nov 12, 2026 by
CPI
Mandating Access to a Dominant Platform’s Inferred Data: A Two Scenario Diagnosis
Nov 12, 2026 by
Sean Ennis
Data Portability Between Individual Control and Data Sharing at Scale
Nov 12, 2026 by
Jasper van den Boom & Inge Graef
Information Also Wants to Be Expensive: Data Portability and the Open-Systems Creed
Nov 12, 2026 by
Justin (Gus) Hurwitz
Data Portability’s Cybersecurity Paradox: When Protecting Consumer Data Restricts Competition
Nov 12, 2026 by
Sasha Hondagneu-Messner